Article

Histone deacetylase inhibitor RG2833 has therapeutic potential for Alzheimer’s disease in females

2023-12-26

Abstract excerpt

Nearly two-thirds of patients with Alzheimer’s are women. Identifying therapeutics specific for women is critical to lowering their elevated risk for developing this major cause of adult dementia. Moreover, targeting epigenetic processes that regulate multiple cellular pathways is advantageous given Alzheimer’s multifactorial nature. Histone acetylation is an epigenetic process heavily involved in memory consolida...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 87e926df-ddeb-536f-b48e-b8de259a8b3d
DOI: 10.1101/2023.12.26.573348

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Histone deacetylase inhibitor RG2833 has therapeutic potential for Alzheimer’s disease in femalesDOI 10.1101/2023.12.26.573348Read

Brain-penetrant histone deacetylase inhibitor RG2833 improves spatial memory in females of an Alzheimer's disease rat modelSemantic proximity Read

M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer’s disease genes and improving memorySemantic proximity Read

Potential Alzheimer’s early biomarkers in a transgenic rat model and benefits of diazoxide/dibenzoylmethane co-treatment on spatial memory and AD-pathologySemantic proximity Read

Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agentsSemantic proximity Read

Histone Deacetylase Inhibition in Alzheimer’s Disease: Molecular Mechanisms, Therapeutic Potential, and Future PerspectivesSemantic proximity Read

Diazoxide/dibenozylmethane treatment mitigates spatial memory deficits and pathology and upregulates protective genes in an Alzheimer’s transgenic rat modelSemantic proximity Read

Epigenetic regulation in Alzheimer’s disease: is it a potential therapeutic target?Semantic proximity Read

Targeting epigenetics: A novel promise for Alzheimer’s disease treatmentSemantic proximity Read

HDAC inhibitor–dependent transcriptome and memory reinstatement in cognitive decline modelsSemantic proximity Read

Epigenetics: A novel therapeutic approach for the treatment of Alzheimer's diseaseSemantic proximity Read

Histone Deacetylase 2 in Alzheimer’s Disease: A Comprehensive Molecular Blueprint for Therapeutic TargetingSemantic proximity Read

Agomelatine drives sex-specific neuroprotection and reduced pathology in rat and human Alzheimer’s modelsSemantic proximity Read